Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?

doi:10.3748/wjg.v27.i27.4252

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6333)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

457

WORD

172

HTML

3235

Figures (1-4)

231

Tables (1-4)

206

Sum=4301

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

243

Download

504

Sum=747

Publishing Process of This Article

Item

Count

Browse

448

Download

837

Sum=1285

Jul 21, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 21, 2021; 27(27): 4252-4275
Published online Jul 21, 2021. doi: 10.3748/wjg.v27.i27.4252

Full Size Figure Download Figure

Figure 4 Therapeutic algorithm for hepatitis B virus-associated intrahepatic cholangiocarcinoma. BSC: Best supportive care; ECOG-PS: Eastern Cooperative Oncology Group-Performance Status; FGFR: Fibroblast growth factor receptor; FOLFOX: Folinic acid, Fluorouracil and Oxaliplatin combination; GEMCIS: Gemcitabine and cisplatin combination; IDH: Isocitrate dehydrogenase.

Citation: Fragkou N, Sideras L, Panas P, Emmanouilides C, Sinakos E. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence? World J Gastroenterol 2021; 27(27): 4252-4275
URL: https://www.wjgnet.com/1007-9327/full/v27/i27/4252.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i27.4252